Item Details

Print View

The Safety and Effectiveness of New Drugs [electronic resource]: (Marketing of Fixed Combination Drugs and Unapproved New Drugs; Implementation of Drug Efficacy Findings). Hearing Before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-Second Congress, First Session. May 26, 1971

United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee
Format
Online; EBook; Government Document
Published
Washington : U.S. Govt. Print. Off., 1971.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
SuDoc Number
Y 4.G74/7:D84/8
Description
iii, 82 p. : ill. ; 23 cm.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1971-OPH-0050
Reproduction Notes
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Staff View

    LEADER 02389nam a22003011a 4500
    001 cis2007436017
    006 m d f
    007 cr bn mmmapmmp
    008 090922s1971 dcua s f000 0 eng d
    043
      
      
    a| n-us---
    086
    0
      
    a| Y 4.G74/7:D84/8
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Government Operations. b| Intergovernmental Relations Subcommittee.
    245
    1
    4
    a| The safety and effectiveness of new drugs h| [electronic resource] : b| (marketing of fixed combination drugs and unapproved new drugs; implementation of drug efficacy findings). Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. May 26, 1971.
    260
      
      
    a| Washington : b| U.S. Govt. Print. Off., c| 1971.
    300
      
      
    a| iii, 82 p. : b| ill. ; c| 23 cm.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1971-OPH-0050
    533
      
      
    a| Electronic reproduction. b| [Bethesda, Md.] : c| ProQuest, d| 2004. e| digital, PDF file. n| ProQuest U.S. Congressional Hearings Digital Collection. n| Mode of access: World Wide Web via ProQuest website.
    538
      
      
    a| System requirements: PDF reader software.
    650
      
    0
    a| Drugs x| Law and legislation z| United States.
    650
      
    0
    a| Drugs x| Effectiveness.
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee. t| safety and effectiveness of new drugs w| (DLC)76614891 //r852
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee. t| safety and effectiveness of new drugs. d| [Bethesda, Md.] : ProQuest,[2004] o| CIS 71 H401-30 w| (ProQuest)cis07100260
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1971-OPH-0050 y| Electronic resource (PDF)
    998
      
      
    a| cis07100260
    040
      
      
    a| UMI c| UMI
▾See more
▴See less

Availability

Read Online